Bank of America’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.3K Buy
5,633
+68
+1% +$197 ﹤0.01% 6078
2025
Q1
$4.01K Buy
5,565
+18
+0.3% +$13 ﹤0.01% 6204
2024
Q4
$5.71K Sell
5,547
-107
-2% -$110 ﹤0.01% 6160
2024
Q3
$7.58K Buy
5,654
+96
+2% +$129 ﹤0.01% 6019
2024
Q2
$7.23K Buy
5,558
+366
+7% +$476 ﹤0.01% 6065
2024
Q1
$8.93K Sell
5,192
-558
-10% -$960 ﹤0.01% 6016
2023
Q4
$8.45K Sell
5,750
-3,032
-35% -$4.46K ﹤0.01% 5972
2023
Q3
$10.6K Sell
8,782
-4,455
-34% -$5.39K ﹤0.01% 5936
2023
Q2
$19.2K Sell
13,237
-5,180
-28% -$7.51K ﹤0.01% 5844
2023
Q1
$26.7K Buy
18,417
+10,479
+132% +$15.2K ﹤0.01% 5864
2022
Q4
$13.7K Sell
7,938
-1,843
-19% -$3.19K ﹤0.01% 6039
2022
Q3
$19K Sell
9,781
-8,794
-47% -$17.1K ﹤0.01% 6197
2022
Q2
$14K Buy
18,575
+8,765
+89% +$6.61K ﹤0.01% 6479
2022
Q1
$85K Sell
9,810
-31,843
-76% -$276K ﹤0.01% 6159
2021
Q4
$667K Buy
41,653
+27,985
+205% +$448K ﹤0.01% 4886
2021
Q3
$251K Buy
13,668
+5,967
+77% +$110K ﹤0.01% 5315
2021
Q2
$107K Sell
7,701
-11,118
-59% -$154K ﹤0.01% 5700
2021
Q1
$277K Buy
18,819
+9,850
+110% +$145K ﹤0.01% 5157
2020
Q4
$174K Sell
8,969
-6,043
-40% -$117K ﹤0.01% 4965
2020
Q3
$167K Sell
15,012
-1,736
-10% -$19.3K ﹤0.01% 4795
2020
Q2
$226K Buy
16,748
+6,829
+69% +$92.2K ﹤0.01% 4626
2020
Q1
$80K Sell
9,919
-8,307
-46% -$67K ﹤0.01% 5056
2019
Q4
$175K Buy
18,226
+3,253
+22% +$31.2K ﹤0.01% 4921
2019
Q3
$159K Buy
14,973
+3,603
+32% +$38.3K ﹤0.01% 5005
2019
Q2
$131K Sell
11,370
-71,069
-86% -$819K ﹤0.01% 5101
2019
Q1
$1.06M Sell
82,439
-570
-0.7% -$7.29K ﹤0.01% 3858
2018
Q4
$510K Buy
83,009
+79,123
+2,036% +$486K ﹤0.01% 4257
2018
Q3
$41K Buy
3,886
+2,005
+107% +$21.2K ﹤0.01% 5549
2018
Q2
$28K Buy
1,881
+1,422
+310% +$21.2K ﹤0.01% 5654
2018
Q1
$6K Sell
459
-510
-53% -$6.67K ﹤0.01% 5979
2017
Q4
$12K Buy
+969
New +$12K ﹤0.01% 5749